Global "Transfection
Reagent & Equipment Market" 2022
Industry research report covers the industry overview with Marketplace Size,
Share, Development, futuristic cost, earnings, demand and distribution data. Its
vast repository offers an analytical summary of the marketplace that can help
to the new and existing player to take a significant decision.
In this report, we
thoroughly examine and analyse the Global market for Transfection Reagent &
Equipment so that market participants can improve their business strategy and
ensure long-term success. This report provides players with useful information
and suggests result-based ideas to give them a competitive advantage in the
global Transfection Reagent & Equipment industry. It will show how other
players compete in the global Transfection Reagent & Equipment Market and
explain the strategies you use to differentiate yourself from other
participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/transfection-reagents-equipment-market/request-sample
Industry Insights
The global Transfection
Reagent & Equipment Market size is estimated to reach USD 1.08 billion by
2022, exhibiting a 7.4% CAGR during the forecast period. The primary factor for
the growth of this segment is the rising demand for the production of the recombinant
protein.
Advancements in the
clinical development of biopharmaceuticals, is anticipated to boost the demand
for gene analysis and gene expression studies for the purpose of
bio-authenticity and investigative analysis. The aforementioned factor is
attributive to drive the segment revenue potentially in the coming years.
Patent cliff generated in
recent years is pronouncing the need for production of several moieties which
depends on the laboratory analysis thus inducing industrial growth in this market.
Anticipated rise in the analytical methods is expected to increase the adoption
of such technologies in the coming years.
Additionally, with
established healthcare infrastructure and reimbursement policy, many pharma
companies are expanding their business in western geographic segments which
would induce innovation and growth in the biotechnology industry over the
forecasted period.
Application Insights
Gene expression accounted
for the largest share of revenue in 2016 as a result of larger use of the
technology in this segment. Vaccine biopharmaceuticals production requires
substantial usage of gene expression methods based on the principles of
transfection.
Proteomic analyzers and
cytology-based programs (for research purpose) are expected to witness demand
in biomedical and oncology studies. This factor is expected to fuel progress in
the coming years.
Regional Insights
North American region
witnessed highest penetration in 2016 owing to the presence of large number of
research and biopharmaceutical production institutes, biosimilar drugs,
vaccines, and clinical organizations for R&D.
With the rise in number of
academic institutes engaged in basic research for protein and genetic research
which are highly supported by the government, the market revenue for
transfection is anticipated to witness potential increment. Also, a large
number of cancer research and specialized biomedical institute provides a
platform for the development of this technology.
Europe with respect to
market share is close to North America and has gained significantly high
revenue as per the estimation. With favorable government policy, large-scale
gene expression analysis is widely implemented in this region. Also,
large-scale development in reverse transfection has provided a strong base for
penetration of the products in this region.
Asia-Pacific region is
expected to witness fastest growth over the forecast period owing to progress
in healthcare infrastructure, for example, setting up of bio-incubators for research
purpose, rise in government funding for basic research held in academic
institutions, increasing adoption of proteomics and cytological expression.
Competitive Insights
Roche, Promega and Life
Technologies (a subsidiary of Thermo Fisher) are renowned players operating in
this market. These players are engaged in implementing strategic initiatives
such as product development, diversification, vertical and horizontal
integration, and in some cases divestiture.
Other companies that are
operating in this market are Lonza, Qiagen, Mirus Bio LLC, OriGene
Technologies, EMD Millipore, VWR International, BTX and SignaGen Laboratory.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment